Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma. - Wikidata - awgldk - TriplyDB

Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma.

Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma.

http://www.wikidata.org/entity/Q37014061

about

Therapeutic cancer vaccines: past, present, and future Gene Expression Profiling and Pathway Network Analysis Predicts a Novel Antitumor Function for a Botanical-Derived Drug, PG2 Challenges and future perspectives of T cell immunotherapy in cancer Clinical targeting of the TNF and TNFR superfamilies Association of CTLA-4 gene polymorphisms -318C/T and +49A/G and Hashimoto's thyroidits in Zahedan, Iran.Non-BRAF targeted therapies for melanoma: protein kinase inhibitors in Phase II clinical trials.Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma.The pan-Aurora kinase inhibitor, PHA-739358, induces apoptosis and inhibits migration in melanoma cell lines.Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer.

P2860

Q26863283-85B1401E-5E04-4740-B204-F6CFA990F9AF Q35564075-6E8DBFBA-DC0A-4274-86CD-ADC0938C7F20 Q35843507-585A956B-649F-4A7B-9648-BA09F4B35100 Q36762882-312989A8-DB48-4EAF-9568-48A23D22F603 Q37593860-64996E7D-F55E-4801-8016-1EA13D893C2E Q38185688-A11FED4A-CAA6-4E71-9F15-CB39FE75FB2E Q38195656-03D5DC44-9DF2-4947-8187-AAD16C6A9853 Q39205891-2E726A2D-B7A1-4C87-8A3B-D13965E7BD96 Q47233994-4C7102F4-3F77-43E0-ACD9-5D2CE0630DD1

P2860

Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma.

http://www.wikidata.org/entity/Q37014061

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Blockade of cytotoxic T-lympho ...... pproach for advanced melanoma.

@en

Blockade of cytotoxic T-lympho ...... pproach for advanced melanoma.

@nl

type

label

Blockade of cytotoxic T-lympho ...... pproach for advanced melanoma.

@en

Blockade of cytotoxic T-lympho ...... pproach for advanced melanoma.

@nl

prefLabel

Blockade of cytotoxic T-lympho ...... pproach for advanced melanoma.

@en

Blockade of cytotoxic T-lympho ...... pproach for advanced melanoma.

@nl

P1433

Q37014061-0A000688-807D-4B32-A228-7338F9C611E0

P1476

Q37014061-08616FA0-0B36-4603-B7EA-75B6FA80960E

P2093

Q37014061-424755F3-177C-42C1-BED3-F0D9AB262596

Q37014061-7774D244-9FA0-40D7-9878-6CE95C29B910

Q37014061-97F7D1D6-273D-4FD1-B91F-15DF5297B1A0

Q37014061-E5254073-B737-45CA-8304-BF13743A91A6

P2860

Q37014061-01409C08-D5CB-418D-BB7A-0E35125526E8

Q37014061-01D48C86-361F-45C2-AA65-177B7A13B6A2

Q37014061-0313B1C9-A7D4-4E59-AB6A-1B84774A9C9E

Q37014061-0436A8D5-D629-4712-AC8C-E66DBF4D295D

Q37014061-05074BE5-F2C5-4F9F-B0B5-C0616F14B691

Q37014061-057AE530-D0B9-4066-BCB2-4B6639FA3D16

Q37014061-08A8EE3B-7954-43CC-AE1F-F9EA36669514

Q37014061-08F9C5B0-4E1A-4925-B589-46999BA23778

Q37014061-0AFCB847-BFD2-4CBF-9025-AA82D6C517C7

Q37014061-0B19F11A-DBAE-4B6F-BB2C-19902F3626C7

P304

Q37014061-04271DE1-3459-4D36-9CA3-E7C27DBD9C90

P31

Q37014061-1128E86C-1237-4295-8D0D-412B67980A08

P356

Q37014061-AD88720E-3617-4279-BDAE-6C083052F9BA

P407

Q37014061-9DF3AAAF-6415-44AE-BC42-AEF82048D923

P433

Q37014061-CA58AA4D-12D9-4A5A-ACF8-65C3AFB021E9

P478

Q37014061-F2F29A81-AE50-4B4A-957E-578657D35705

P577

Q37014061-D90FBDC7-D98C-4A27-B33E-429A8D29835E

P698

Q37014061-20858EF4-44E6-4930-B571-12275D29840E

P921

Q37014061-A2536106-9140-44A0-93FD-371545539EA2

Q37014061-CC31D11C-3FE9-4438-AA20-9AD562B9F83B

P932

Q37014061-F6BA34C5-CF16-4979-86C1-6CFD0963B663

P356

14656566.2011.629187

P1433

Expert Opinion on Pharmacotherapy

P1476

Blockade of cytotoxic T-lympho ...... pproach for advanced melanoma.

@en

P2093

Daming Zuo

http://www.w3.org/2001/XMLSchema#string

Devanand Sarkar

http://www.w3.org/2001/XMLSchema#string

Paul B Fisher

http://www.w3.org/2001/XMLSchema#string

Xiang-Yang Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Structure-Function analysis of the CTLA-4 interaction with PP2A

Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

CD28/B7 system of T cell costimulation

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma

CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms

Extended dose ipilimumab with a peptide vaccine: immune correlates associated with clinical benefit in patients with resected high-risk stage IIIc/IV melanoma

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

P304

2695-2706

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2011.629187

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22077831

http://www.w3.org/2001/XMLSchema#string

P921

P932

3711751

http://www.w3.org/2001/XMLSchema#string